Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2010
12/02/2010US20100303820 Methods of treatment using il-17e antagonists
12/02/2010US20100303819 Dcl-1 and uses thereof
12/02/2010US20100303801 Host cell specific binding molecules capable of neutralizing viruses and uses thereof
12/02/2010US20100303799 Treatment of Conditions Related to Shock
12/02/2010US20100303782 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
12/02/2010US20100303761 Lipidized Interferon and Uses Thereof
12/02/2010US20100303760 Treatment and/or prevention of cancer and/or arthritis
12/02/2010US20100303759 polynucleotide encoding a protein that is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b); treating cancer responsive to interferon alpha therapy
12/02/2010US20100303755 Hepatitis C Virus Inhibitors
12/02/2010US20100303754 Process for preparation of cyclodextrin oligomers or polymers, products obtained and uses
12/02/2010US20100303744 Personal-care composition comprising oil-soluble solid sunscreens
12/02/2010US20100303743 Personal Care Compositions Containing Hydrophobic Silicone-Organic Gel Blends
12/02/2010DE102009022794A1 Verwendung von Hemmstoffen der HAT und TMPRSS2 als Arzneimittel Use of inhibitors of HAT and TMPRSS2 as drugs
12/02/2010DE102009022618A1 New hydropyrone derivatives useful as biocide, antibiotics, fungicide, antioomycetes, inhibitor for enzymes, disinfectant, textile modifier and wood preservative
12/02/2010CA2769769A1 Oxazolidinone containing dimer compounds, compositions and methods to make and use
12/02/2010CA2763485A1 Methods for treating cancer and non-neoplastic conditions
12/02/2010CA2763246A1 Ketolide compounds having antimicrobial activity
12/02/2010CA2763140A1 Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
12/01/2010EP2256210A1 Wickerol and process for production thereof
12/01/2010EP2256205A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/01/2010EP2256204A1 Porphorymonas gingivalis polypeptides and polynucleotides
12/01/2010EP2256199A1 Therapeutic uses of BR43X2 soluble receptors
12/01/2010EP2256113A1 Inhibitors of serine proteases
12/01/2010EP2256106A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
12/01/2010EP2255827A1 Vaccines comprising aluminium adjuvants and histidine
12/01/2010EP2255826A2 Neisserial vaccine compositions comprising a combination of antigens
12/01/2010EP2255823A1 Intestinal immune system stimulator
12/01/2010EP2255815A2 Nutritional Composition
12/01/2010EP2255801A1 Pharmaceutically active isoindoline derivatives
12/01/2010EP2255668A2 Production and Use of a Polar Lipid-Rich Fraction Containing Omega-3 and/or Omega-6 Highly Unsaturated Fatty Acids from Microbes, Genetically Modified Plant Seeds and Marine Organisms
12/01/2010EP2255661A2 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
12/01/2010EP2255624A1 Inhibitor for growth of bacteria of genus legionella, bath agent and cleaning agent
12/01/2010EP2255194A1 Methods for prognosing the status of tumor patients
12/01/2010EP2254893A1 Novel 7-substituted derivatives of 3-carboxy-oxadiazino-quinolones, preparation thereof and use thereof as anti-bacterial agents
12/01/2010EP2254892A1 Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones
12/01/2010EP2254887A1 Oxazolidinone derivatives
12/01/2010EP2254595A1 Methods and compositions for reducing the impact of enteric diseases
12/01/2010EP2254593A2 Immunogenic influenza composition
12/01/2010EP2254592A2 Mhc multimers in borrelia diagnostics and disease
12/01/2010EP2254591A2 Inhibition and treatment of gastrointestinal biofilms
12/01/2010EP2254582A2 Methods of treating viral infections
12/01/2010EP2254574A1 Beta-lactones as antibacterial agents
12/01/2010EP1791601B1 Novel vaccine for veterinary and human medicine prophylaxis and therapy
12/01/2010EP1427441B1 COMPOSITE SUPERIMMUNOGEN FOR BI-FUNCTIONAL VACCINE Tat-gp160 FOR USE IN THE TREATMENT OF AIDS
12/01/2010EP1414996B1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
12/01/2010EP1414861B1 Humanized antibodies against icam-1, their production and uses
12/01/2010EP1401457B1 Strain of micro-organism lactobacillus fermentum me-3 as novel antioxidative probiotic
12/01/2010EP1322156B3 Disinfectant
12/01/2010EP1244790B1 Nucleic acids encoding polypeptides having chips activity
12/01/2010CN1997352B Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
12/01/2010CN1895325B Quality control for sedum sarmentosum and its preparation
12/01/2010CN1872073B Drop pills of oleanolic acid, and preparation method
12/01/2010CN1872050B Drop pills of silymarin, and preparation method
12/01/2010CN1847261B Cyclic peptides as g-protein-coupled receptor antagonists
12/01/2010CN1824675B Neisserial antigens
12/01/2010CN1784493B Modified beta-lactamases and uses thereof
12/01/2010CN1646154B Albumin-fused anti-angiogenesis peptides
12/01/2010CN1464789B Vaccine against the influenza virus and method for producing said virus vaccine
12/01/2010CN101903392A Inhibitors of serine proteases
12/01/2010CN101903389A Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy
12/01/2010CN101903382A Heterocyclic antiviral compounds
12/01/2010CN101903380A 5-aminocyclylmethyl-oxazolidin-2-one derivatives
12/01/2010CN101903371A Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide
12/01/2010CN101903353A Aminopyrazole derivatives
12/01/2010CN101903351A 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/01/2010CN101903042A Fish vaccine
12/01/2010CN101903026A Methods of treating a flaviviridae family viral infection and compositions for treating a flaviviridae family viral infection
12/01/2010CN101902914A Azolylmethyloxiranes, use thereof and agents containing the same
12/01/2010CN101899471A Recombinant retrovirus vector for simultaneously expressing antigen-specific receptor and exogenous gene, B-lymphocyte modified by using same and application thereof
12/01/2010CN101899469A Shuttle plasmid and method for efficiently expressing cecropin and lysozyme genes
12/01/2010CN101899466A Dengue virus and Japanese encephalitis virus embedded pseudo virus particle vaccine and preparation method thereof
12/01/2010CN101899465A Recombinant J subgroup avian leucosis virus infective cloned plasmids and preparation method and application thereof
12/01/2010CN101899461A Fusion gene capable of encoding influenza A virus NP protein and M2e polypeptide
12/01/2010CN101899440A Structure and use of PITPNM2 targeted anti-dengue virus oligonucleotide
12/01/2010CN101899421A Recombinant baculovirus and construction method and application thereof
12/01/2010CN101899418A Avian influenza virus (AIV) as well as kit and vaccine used for detecting and preventing same
12/01/2010CN101899416A Recombinant rat myeloma cell NS0-F10 and application thereof
12/01/2010CN101899108A Novel polypeptide based on human TLR9 receptor functional domain segment LRR11 and applications thereof
12/01/2010CN101899101A Synthetic polypeptide for researching influenza virus subunit vaccine
12/01/2010CN101899100A Anti-HIV-I (Human Immunodeficiency Virus-I) polypeptides as well as coding sequences and applications thereof
12/01/2010CN101899099A X4 peptide synthetic product and application thereof
12/01/2010CN101899093A X2 polypeptide synthesis product and application thereof.
12/01/2010CN101899078A Extraction method of glossy privet fruit glycoside and application of glossy privet fruit glycoside in preparation of medicament
12/01/2010CN101899076A Azithromycin derivative, preparation method and intermediate thereof
12/01/2010CN101899075A Beta-N-glucosylated-alpha-aminophosphonate compound
12/01/2010CN101899073A B Methyl-5-deoxidation-(dialkyl phosphate)-5-(dialkyl phosphamide)-2, 3-O-propylidene-belta-D-furanoside-contained compound
12/01/2010CN101899066A 2-[(diethoxy thiophosphamide) methyl]-4-aryl-5,5-dimethyl-1,3,2-dioxide phospha cyclohexane compound
12/01/2010CN101899059A Pyrrolidine-containing dicyclic cephalosporin derivatives
12/01/2010CN101899047A Beta-amino tetrahydropyrazine, tetrahydropyrimidine and tetrahydropyridine used as dipeptidy peptidase inhibitors for curing or preventing diabetes
12/01/2010CN101899017A Benzsulfamide compound with function of inhibiting HIV-1 (Human Immunodeficiency Virus type 1) capsid protein, preparation method and application thereof
12/01/2010CN101899013A 2-(2-substituted aryl-2H-1,2,4-triazole-3-sulfydryl) acetamide derivative and preparation method and application thereof
12/01/2010CN101899006A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
12/01/2010CN101898966A Bromine and piperazine ring-containing Artemisia rupestris L. keto ester derivative as well as preparation method and application thereof
12/01/2010CN101897983A Monocyte-specific particulate delivery vehicle
12/01/2010CN101897970A Compositions and methods for treating diabetes
12/01/2010CN101897966A Cynomorium songaricum immunological adjuvant and influenza vaccine comprising same
12/01/2010CN101897965A Hepatitis B virus dendritic cell therapeutic vaccine and preparation method thereof
12/01/2010CN101897963A Vaccine for hand-foot-and-mouth disease viruses
12/01/2010CN101897953A Non-invasive high-penetrability epidermal growth factor and application thereof
12/01/2010CN101897951A Anti-inflammatory effect of novel anti-inflammatory molecular DRP, implementation method and application